PerkinElmer, Inc. (0KHE.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 06:19PM BST
| Previous close | 151.13 |
| Open | 158.85 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 158.85 - 158.85 |
| 52-week range | 158.85 - 158.85 |
| Volume | |
| Avg. volume | N/A |
| Market cap | 17.515B |
| Beta (5Y monthly) | 1.13 |
| PE ratio (TTM) | 15.85 |
| EPS (TTM) | 10.02 |
| Earnings date | 02 May 2022 - 06 May 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
PerkinElmer (PKI) Q2 Earnings and Revenues Surpass Estimates
PerkinElmer's (PKI) second-quarter results benefit from a solid performance at Discover & Analytics Solutions business.
- Reuters
PerkinElmer divests three business units in $2.45 billion deal
(Reuters) -PerkinElmer Inc on Monday agreed to sell three of its businesses to private equity firm New Mountain Capital for up to $2.45 billion in cash, as it looks to focus on its life sciences and diagnostics businesses under a new name. Last week, 3M Co announced it would spin off its healthcare unit, while Labcorp agreed to separate its clinical development business. Direct lenders led by Owl Rock Capital Corp helped finance the deal entirely, amid a slowdown in the business of acquisition financing as both traditional and direct lenders have pulled back from lending on leveraged buyouts in recent weeks.
© 2022 Yahoo. All rights reserved.
